Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -14,142.61% | -3,300.09% | -3,645.95% | -18,301.34% |
| EV / EBITDA | -10.76 | -9.44 | -7.71 | -7.09 |
| Quality | ||||
| ROIC | -9.13% | -9.31% | -10.48% | -8.08% |
| Gross Margin | -20.62% | -14.26% | -32.28% | -11.72% |
| Cash Conversion Ratio | 0.61 | 0.93 | 0.44 | 1.32 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.66% | 3.43% | 28.40% | 34.78% |
| Free Cash Flow Growth | -106.18% | 34.69% | 46.38% | -52.48% |
| Safety | ||||
| Net Debt / EBITDA | -10.75 | -9.41 | -7.67 | -7.08 |
| Interest Coverage | -2.75 | -2.79 | -4.36 | -6.21 |
| Efficiency | ||||
| Inventory Turnover | 13.85 | 15.22 | 7.36 | 14.25 |
| Cash Conversion Cycle | -82.15 | -2.92 | 64.53 | 244.55 |